ArticlePharmacoepidemiology and drug safety2017

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

Yi-Ting Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.